Ionotropic glutamate receptor antagonists and cancer therapy: time to think out of the box? Mariana P. C. RibeiroJosé B. A. CustódioArmanda E. Santos Review Article 01 September 2016 Pages: 219 - 225
The role of microRNAs in resistance to targeted treatments of non-small cell lung cancer Hongjing ZangWeiyuan WangSongqing Fan Review Article 11 August 2016 Pages: 227 - 231
Irinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues Bronwen J. MayoAndrea M. StringerDorothy M. Keefe Review Article 21 October 2016 Pages: 233 - 249
Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors Elham AjorlouAhmad Yari Khosroushahi Review Article 15 October 2016 Pages: 251 - 265
Clinical research on rare diseases of children: neuroblastoma Chiara GerardiRita BanziSilvio Garattini Review Article 22 November 2016 Pages: 267 - 273
On-treatment markers as predictors to guide anti-EGFR MoAb treatment in metastatic colorectal cancer: a systematic review with meta-analysis Jing HuZhen ZhangXiaoping Qian Review Article 22 November 2016 Pages: 275 - 285
Research progress of hydroxychloroquine and autophagy inhibitors on cancer Ting-Ting ShiXiao-Xu YuHong-Tao Xiao Review Article 26 November 2016 Pages: 287 - 294
Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells Jan S. MorebDeniz A. Ucar-BilyeuAbdullah Khan Review Article 10 December 2016 Pages: 295 - 301
Pharmacology and toxicology of the novel investigational agent Cantrixil (TRX-E-002-1) Muhammad Wasif SaifAndrew HeatonDavid M. Brown Review Article Open access 24 December 2016 Pages: 303 - 314
Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer Jeffrey R. InfanteAmita PatnaikRoger B. Cohen Original Article 17 January 2017 Pages: 315 - 326
Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205 Hong-Yan ZhangFeng LiangXi-Gang Kang Original Article 06 January 2017 Pages: 327 - 337
Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study John SarantopoulosAlain C. MitaOlivier Rixe Original Article Open access 05 January 2017 Pages: 339 - 351
Pharmacokinetic and exposure–response analyses of pertuzumab in combination with trastuzumab and docetaxel during neoadjuvant treatment of HER2+ early breast cancer Angelica L. QuartinoHanbin LiAmit Garg Original Article Open access 10 January 2017 Pages: 353 - 361
Myeloprotective effects of C-type natriuretic peptide on cisplatin-induced bone marrow granulocytopenia in mice Masahiro ZenitaniTakashi NojiriKenji Kangawa Original Article 18 January 2017 Pages: 363 - 368
The role of Nrf2 and ATF2 in resistance to platinum-based chemotherapy Jianli ChenCharalambos SolomidesHenry Simpkins Original Article 24 January 2017 Pages: 369 - 380
Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small-cell lung cancer Samer TabchiNormand BlaisMustapha Tehfe Original Article 12 January 2017 Pages: 381 - 387
Molecular explorations of substituted 2-(4-phenylquinolin-2-yl) phenols as phosphoinositide 3-kinase inhibitors and anticancer agents Manikandan AlagumuthuSivakumar Arumugam Original Article 04 January 2017 Pages: 389 - 397
Modulation of cyclophosphamide-induced cardiotoxicity by methyl palmitate Dina S. El-AgamyMohamed A. ElkablawyHany M. Abo-Haded Original Article 27 January 2017 Pages: 399 - 409
Reduced proliferation and colony formation of head and neck squamous cell carcinoma (HNSCC) after dual targeting of EGFR and hedgehog pathways Hannes LiebigGeorg GüntherGunnar Wichmann Original Article 21 January 2017 Pages: 411 - 420
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC) Ghassan K. Abou-AlfaChia-Jui YenJorge A. Carrasquilo Original Article 24 January 2017 Pages: 421 - 429
Potential safety concerns of TLR4 antagonism with irinotecan: a preclinical observational report Janet K. CollerJoanne M. BowenRachel J. Gibson Short Communication 23 December 2016 Pages: 431 - 434
Comment to: GSTP1, GSTM1 and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis Sarah CargninSalvatore Terrazzino Letter to the Editor 06 January 2017 Pages: 435 - 436
Methotrexate neurotoxicity due to drug interactions: an inadequate folinic acid effect? Ian Joseph Cohen Letter to the Editor 09 January 2017 Pages: 437 - 437